evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract,articles/20/pmid,articles/20/title,articles/20/journal,articles/20/pubDate,articles/20/volume,articles/20/issue,articles/20/pages,articles/20/authors,articles/20/elocationId,articles/20/link,articles/20/reference,articles/20/abstract
18544,GENE_SUMMARY,,"SOX2 encodes a transcription factor involved in embryonic development and cell fate. Amplifications of SOX2 are found in glioblastomas, small cell lung cancers and squamous cell carcinomas.",,2017-01-18,,6657,SOX2,SRY-box 2,False,ENST00000325404,NM_003106.3,ANOP3,MCOPS3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18545,GENE_BACKGROUND,,"SOX2 encodes a transcriptional factor essential to embryonic stem cell development and the determination of cell fate. It functions as an activator or suppressor of gene transcription through a highly specific DNA binding (high-mobility group) domain (PMID: 20016762). Together with Oct-4 and Nanog, Sox2 positive regulates transcription of pluripotency factors involved in the Leukemia inhibitory factor signaling pathway (PMID:19571885). SOX2 has recently been implicated in cancer development, by promoting oncogenic signaling and maintaining cancer stem cells. It has been shown to promote cellular proliferation in breast (PMID: 22561374), prostate (PMID: 24659665), pancreatic (PMID: 23917223) and cervical cancers (PMID: 21415100); and to evade apoptotic signaling in prostate (PMID: 24325912), gastric cancer (PMID: 21415100) and non small cell lung cancer (PMID: 24233838). SOX2 has also been associated with an increased in the metastatic potential of these cancers (PMID: 22069467, 22184093, 22912670, 23895273). SOX2 amplification is observed in several cancer types including glioblastoma, small-cell lung cancer and many forms of squamous cell carcinoma (PMID: 20126410, 21518820, 22069467, 20372069, 19801978, 21334718, 22941189, 19787784). Its heterozygous mutations have been associated with developmental disorders, such as aanophthalmia-esophagel-genital (AEG) syndrome (PMID: 16543359) and syndromic microphthalmia, a structural eye malformation (PMID: 23463581).",,2017-01-18,,6657,SOX2,SRY-box 2,False,ENST00000325404,NM_003106.3,ANOP3,MCOPS3,False,16543359,Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.,Human molecular genetics,2018-05-01T20:06:00,15,9,1413-22,Williamson KA et al,,,0001-05-01,,20372069,SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.,"Cell cycle (Georgetown, Tex.)",2018-04-15T20:10:00,9,8,1480-6,Hussenet T et al,,,0001-04-15,,23895273,SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention.,Omics : a journal of integrative biology,2018-10-01T20:13:00,17,10,510-8,Lou X et al,doi: 10.1089/omi.2013.0058,,0001-10-01,,24233838,SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.,Carcinogenesis,2018-03-01T20:14:00,35,3,613-23,Chen S et al,doi: 10.1093/carcin/bgt371,,0001-03-01,,23463581,Aplasia cutis congenita of the scalp in a female infant with anophthalmia/microphthalmia-esophageal atresia syndrome negative for SOX2 mutation.,American journal of medical genetics. Part A,2018-05-01T20:13:00,161A,5,1189-93,Corona-Rivera JR et al,doi: 10.1002/ajmg.a.35854,,0001-05-01,,24659665,Expression of Sox2 in cervical squamous cell carcinoma.,Journal of B.U.ON. : official journal of the Balkan Union of Oncology,2018-01-01T20:14:00,19,True,203-6,Yang Z et al,,,0001-01-01,,22069467,Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.,PloS one,2011,6,11,e26740,Alonso MM et al,doi: 10.1371/journal.pone.0026740,,Alonso MM et al. PloS one. 2011;6(11)e26740.,,19801978,SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.,Nature genetics,2018-11-01T20:09:00,41,11,1238-42,Bass AJ et al,doi: 10.1038/ng.465,,0001-11-01,,22941189,Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.,Nature genetics,2018-10-01T20:12:00,44,10,1111-6,Rudin CM et al,doi: 10.1038/ng.2405,,0001-10-01,,19787784,Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma.,"Genes, chromosomes &amp; cancer",2018-01-01T20:10:00,49,True,2001-09-16,Freier K et al,doi: 10.1002/gcc.20714,,0001-01-01,,21415100,SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell.,Journal of molecular cell biology,2018-08-01T20:11:00,3,4,230-8,Jia X et al,doi: 10.1093/jmcb/mjr002,,0001-08-01,,23917223,SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells.,Oncogenesis,2018-08-05T20:13:00,2,,e61,Herreros-Villanueva M et al,doi: 10.1038/oncsis.2013.23,,0001-08-05,,24325912,The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.,Carcinogenesis,2018-04-01T20:14:00,35,4,942-50,HÃ¼tz K et al,doi: 10.1093/carcin/bgt410,,0001-04-01,,21334718,SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.,Human pathology,2018-08-01T20:11:00,42,8,1078-88,Maier S et al,doi: 10.1016/j.humpath.2010.11.010,,0001-08-01,,22561374,Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer.,Nucleic acids research,2018-08-01T20:12:00,40,14,6725-40,Stolzenburg S et al,,,0001-08-01,,21518820,SOX2 expression and amplification in gliomas and glioma cell lines.,Cancer genomics &amp; proteomics,2018-05-01T20:11:00,8,3,139-47,Annovazzi L et al,,,0001-05-01,,19571885,A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.,Nature,2018-07-02T20:09:00,460,7251,118-22,Niwa H et al,doi: 10.1038/nature08113,,0001-07-02,,22912670,Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients.,PloS one,2012,7,8,e41335,Han X et al,doi: 10.1371/journal.pone.0041335,,Han X et al. PloS one. 2012;7(8)e41335.,,20016762,2002-03-04,Wiley interdisciplinary reviews. Systems biology and medicine,2018-09-01T20:09:00,True,2,228-36,Rizzino A,doi: 10.1002/wsbm.12,,0001-09-01,,20126410,SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.,PloS one,2018-01-29T20:10:00,5,True,e8960,Hussenet T et al,doi: 10.1371/journal.pone.0008960,,0001-01-29,,22184093,SOX2 contributes to melanoma cell invasion.,Laboratory investigation; a journal of technical methods and pathology,2018-03-01T20:12:00,92,3,362-70,Girouard SD et al,doi: 10.1038/labinvest.2011.188,,0001-03-01,
